<?xml version="1.0" encoding="UTF-8"?>
<table-wrap id="T1" position="float">
 <label>Table 1</label>
 <caption>
  <p>The reported cases of acyclovir/valacyclovir neurotoxicity in the literature</p>
 </caption>
 <table frame="hsides" rules="groups">
  <thead align="center">
   <tr>
    <td rowspan="2" align="left" colspan="1">
     <bold>Author</bold>
    </td>
    <td rowspan="2" colspan="1">
     <bold>Year of publication</bold>
    </td>
    <td rowspan="1" colspan="1">
     <bold>Patient</bold>
    </td>
    <td rowspan="2" colspan="1">
     <bold>Stage of CKD</bold>
    </td>
    <td rowspan="2" colspan="1">
     <bold>Renal replacement manner</bold>
    </td>
    <td rowspan="2" colspan="1">
     <bold>Dosage (mg/d)</bold>
    </td>
    <td rowspan="2" colspan="1">
     <bold>Duration of antiviral treatment</bold>
    </td>
    <td rowspan="2" colspan="1">
     <bold>Concomi-tant medication</bold>
    </td>
    <td rowspan="2" colspan="1">
     <bold>Neuropsy-chiatric symptoms</bold>
    </td>
    <td rowspan="2" colspan="1">
     <bold>Outcome</bold>
    </td>
   </tr>
   <tr>
    <td rowspan="1" colspan="1">
     <bold>sex/age</bold>
    </td>
   </tr>
  </thead>
  <tbody align="center">
   <tr>
    <td align="left" rowspan="1" colspan="1">Pipili et al[
     <xref rid="B18" ref-type="bibr">18</xref>]
    </td>
    <td rowspan="1" colspan="1">2013</td>
    <td rowspan="1" colspan="1">Female/72</td>
    <td rowspan="1" colspan="1">ESRD</td>
    <td rowspan="1" colspan="1">PD</td>
    <td rowspan="1" colspan="1">Valacyclovir tablets 3 g daily for 3 d</td>
    <td rowspan="1" colspan="1">3 d</td>
    <td rowspan="1" colspan="1">Nifedipine, irbesartan, cinacalcet, atorvastatin, alfacalcidol</td>
    <td rowspan="1" colspan="1">Confusion and visual hallucinations</td>
    <td rowspan="1" colspan="1">3 d, restored after PD 6 × 2 L per day</td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">Chaudhari et al[
     <xref rid="B16" ref-type="bibr">16</xref>]
    </td>
    <td rowspan="1" colspan="1">2014</td>
    <td rowspan="1" colspan="1">Male/66</td>
    <td rowspan="1" colspan="1">ESRD</td>
    <td rowspan="1" colspan="1">PD</td>
    <td rowspan="1" colspan="1">Oral valacyclovir 1000 mg daily for 7 d</td>
    <td rowspan="1" colspan="1">7 d</td>
    <td rowspan="1" colspan="1">Simvastatin, metoprolol, sevelamer, furosemide, and glimepiride</td>
    <td rowspan="1" colspan="1">Hallucination, insomnia, and photosensi-tivity</td>
    <td rowspan="1" colspan="1">7 d, improved after regular regimen and hydration</td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">Asahi et al[
     <xref rid="B17" ref-type="bibr">17</xref>]
    </td>
    <td rowspan="1" colspan="1">2009</td>
    <td rowspan="1" colspan="1">Female/78</td>
    <td rowspan="1" colspan="1">Without previous renal failure</td>
    <td rowspan="1" colspan="1">NO</td>
    <td rowspan="1" colspan="1">Valacyclovir 3000 mg/d</td>
    <td rowspan="1" colspan="1">6 d</td>
    <td rowspan="1" colspan="1">Not mentioned</td>
    <td rowspan="1" colspan="1">Unconsciou-sness</td>
    <td rowspan="1" colspan="1">5 d, recovered 14 d later</td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">Asahi et al[
     <xref rid="B17" ref-type="bibr">17</xref>]
    </td>
    <td rowspan="1" colspan="1">2009</td>
    <td rowspan="1" colspan="1">Male/73</td>
    <td rowspan="1" colspan="1">ESRD</td>
    <td rowspan="1" colspan="1">Hemodialysis</td>
    <td rowspan="1" colspan="1">Valacyclovir 3000 mg/d</td>
    <td rowspan="1" colspan="1">2 d</td>
    <td rowspan="1" colspan="1">Not mentioned</td>
    <td rowspan="1" colspan="1">Confusion, hallucination</td>
    <td rowspan="1" colspan="1">2 d, completely recovered 3 d later</td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">Singh et al[
     <xref rid="B19" ref-type="bibr">19</xref>]
    </td>
    <td rowspan="1" colspan="1">2014</td>
    <td rowspan="1" colspan="1">Female/58</td>
    <td rowspan="1" colspan="1">ESRD</td>
    <td rowspan="1" colspan="1">HD</td>
    <td rowspan="1" colspan="1">Valacyclovir 500 mg/d</td>
    <td rowspan="1" colspan="1">2 d</td>
    <td rowspan="1" colspan="1">Not mentioned</td>
    <td rowspan="1" colspan="1">Altered sensorium, irritability, drowsiness, confusion</td>
    <td rowspan="1" colspan="1">2 d, completely recovered 5 d later</td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">Kambham-pati et al[
     <xref rid="B20" ref-type="bibr">20</xref>]
    </td>
    <td rowspan="1" colspan="1">2011</td>
    <td rowspan="1" colspan="1">Female/49</td>
    <td rowspan="1" colspan="1">ESRD</td>
    <td rowspan="1" colspan="1">Maintenance hemodialysis</td>
    <td rowspan="1" colspan="1">Valacyclovir 1000 mg three times a day</td>
    <td rowspan="1" colspan="1">2 d</td>
    <td rowspan="1" colspan="1">Not mentioned</td>
    <td rowspan="1" colspan="1">Disoriented, confused, agitated, hallucinating, delirious, incoherent</td>
    <td rowspan="1" colspan="1">1 d, 4000 mg, completely recovered after second session of hemodialysis</td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">Prasad et al[
     <xref rid="B14" ref-type="bibr">14</xref>]
    </td>
    <td rowspan="1" colspan="1">2017</td>
    <td rowspan="1" colspan="1">Female/57</td>
    <td rowspan="1" colspan="1">ESRD</td>
    <td rowspan="1" colspan="1">PD</td>
    <td rowspan="1" colspan="1">1000 mg three times per day of valacyclovir</td>
    <td rowspan="1" colspan="1">3 d</td>
    <td rowspan="1" colspan="1">Not mentioned</td>
    <td rowspan="1" colspan="1">Confusion and altered sensorium</td>
    <td rowspan="1" colspan="1">1 day, completely recovered 24 h later</td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">Izzedine et al[
     <xref rid="B21" ref-type="bibr">21</xref>]
    </td>
    <td rowspan="1" colspan="1">2001</td>
    <td rowspan="1" colspan="1">Female/60</td>
    <td rowspan="1" colspan="1">ESRD</td>
    <td rowspan="1" colspan="1">PD</td>
    <td rowspan="1" colspan="1">Valacyclovir 500 mg daily</td>
    <td rowspan="1" colspan="1">Reduced 500 mg of valacyclovir every 2 d</td>
    <td rowspan="1" colspan="1">Not mentioned</td>
    <td rowspan="1" colspan="1">Disorientated with ocular and auditory hallucinations and loss of decorum without torpor or coma.</td>
    <td rowspan="1" colspan="1">3 d, recovered 48 h later</td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">Strumia et al[
     <xref rid="B22" ref-type="bibr">22</xref>]
    </td>
    <td rowspan="1" colspan="1">2004</td>
    <td rowspan="1" colspan="1">Male/81</td>
    <td rowspan="1" colspan="1">ESRD</td>
    <td rowspan="1" colspan="1">Hemodialysis</td>
    <td rowspan="1" colspan="1">Oral valacyclovir 1000 mg every 8 h then intravenous acyclovir in full dosage</td>
    <td rowspan="1" colspan="1">3 d</td>
    <td rowspan="1" colspan="1">Not mentioned</td>
    <td rowspan="1" colspan="1">Visual hallucination, confusion and disorientation</td>
    <td rowspan="1" colspan="1">3 daysd completely recovered 6 d later</td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">Linssen-Schuurmans et al[
     <xref rid="B23" ref-type="bibr">23</xref>]
    </td>
    <td rowspan="1" colspan="1">1998</td>
    <td rowspan="1" colspan="1">Male/58</td>
    <td rowspan="1" colspan="1">CKD</td>
    <td rowspan="1" colspan="1">Intermittent hemodialysis twice a week</td>
    <td rowspan="1" colspan="1">Valacyclovir 3 g/d</td>
    <td rowspan="1" colspan="1">2 d</td>
    <td rowspan="1" colspan="1">Not mentioned</td>
    <td rowspan="1" colspan="1">Dizziness, hallucinations, loss of decorum, disoriented, slurred speech</td>
    <td rowspan="1" colspan="1">1 d, complete recovery</td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">Takayanagi et al[
     <xref rid="B24" ref-type="bibr">24</xref>]
    </td>
    <td rowspan="1" colspan="1">2010</td>
    <td rowspan="1" colspan="1">Male/67</td>
    <td rowspan="1" colspan="1">ESRD</td>
    <td rowspan="1" colspan="1">PD</td>
    <td rowspan="1" colspan="1">Valacyclovir, 1 g/d</td>
    <td rowspan="1" colspan="1">5 d</td>
    <td rowspan="1" colspan="1">Not mentioned</td>
    <td rowspan="1" colspan="1">Hallucina-tions</td>
    <td rowspan="1" colspan="1">7 d, complete recovery</td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">Sadjadi et al[
     <xref rid="B25" ref-type="bibr">25</xref>]
    </td>
    <td rowspan="1" colspan="1">2018</td>
    <td rowspan="1" colspan="1">Male/80</td>
    <td rowspan="1" colspan="1">ESRD</td>
    <td rowspan="1" colspan="1">PD</td>
    <td rowspan="1" colspan="1">Acyclovir 5 mg/kg intravenously, followed by oral acyclobir 400 mg/d</td>
    <td rowspan="1" colspan="1">3 d</td>
    <td rowspan="1" colspan="1">Not mentioned</td>
    <td rowspan="1" colspan="1">Confusion, delusion, disorientation, restlessness, visual hallucinations, seizures</td>
    <td rowspan="1" colspan="1">2 d, complete recovery</td>
   </tr>
  </tbody>
 </table>
 <table-wrap-foot>
  <fn>
   <p>CKD: Chronic kidney disease; ESRD: End-stage renal disease; PD: Peritoneal dialysis.</p>
  </fn>
 </table-wrap-foot>
</table-wrap>
